LifeVantage Corporation (LFVN)

Market Cap	149.11M
Revenue (ttm)	222.35M
Net Income (ttm)	9.15M
Shares Out	12.55M
EPS (ttm)	0.70
PE Ratio	16.95
Forward PE	10.90
Dividend	$0.20 (1.68%)
Ex-Dividend Date	May 30, 2025

Volume	371,673
Open	11.76
Previous Close	11.18
Day's Range	11.75 - 13.03
52-Week Range	5.22 - 27.38
Beta	0.44
Analysts	Strong Buy
Price Target	30.50 (+156.73%)
Earnings Date	May 6, 2025

About LFVN

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, and skin and hair care products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; LifeVantage IC Bright, a supplement to support eye and brain health, reduc...

• Industry: Packaged Foods
• Sector: Consumer Staples
• CEO: Steven Fife
• Employees: 222
• Stock Exchange: NASDAQ
• Ticker Symbol: LFVN
• Website: https://www.lifevantage.com

Financial Performance

In 2024, LifeVantage's revenue was $200.16 million, a decrease of -6.20% compared to the previous year's $213.40 million. Earnings were $2.94 million, an increase of 15.63%.

Analyst Forecast

According to 2 analysts, the average rating for LFVN stock is "Strong Buy." The 12-month stock price forecast is $30.5, which is an increase of 156.73% from the latest price.

Price Target

$30.5

(156.73% upside)

Analyst Consensus: Strong Buy